ISI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ionis Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 73.8 EUR 2.44% Market Closed

Market Cap: €5.6B

I	Ionis Pharmaceuticals Inc XMUN:ISI	US
	London Stock Exchange Group PLC F:LS4D	UK
R	Realty Income Corp XMUN:RY6	US
D	Dunelm Group PLC F:DFQ	UK
A	Applied Materials Inc F:AP2	US
T	Tompkins Financial Corp AMEX:TMP	US
M	Mitsubishi Estate Co Ltd XMUN:MES	JP
	Daito Trust Construction Co Ltd OTC:DITTF	JP
S	Star7 SpA F:EH2	IT

Profitability Summary

Ionis Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

99%

Declining Gross Margin

99% > 98%

Negative Operating Margin

-33%

Negative 3Y Average Operating Margin

-51%

Operating Margin is Increasing

-75% > -33%

Negative Net Margin

-31%

Negative 3Y Average Net Margin

-46%

Net Margin is Increasing

-49% > -31%

Negative Free Cash Flow Margin

-92%

Negative 3Y Average Free Cash Flow Margin

-57%

Declining Free Cash Flow Margin

-77% > -92%

Negative ROE

-68%

Negative 3Y Average ROE

Positive 3Y Average ROIC

20%

Declining ROIC

-105% > -258%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.